An anonymous survey from New Zealand among people suffering from inflammatory bowel disease and using cannabis found: 32 percent of these people use cannabis to treat the symptoms of their disease. Survey among people with inflammatory bowel disease The number of people suffering from inflammatory bowel disease is increasing worldwide. In 2017, 140 to 160 […]
Almost three quarters of cannabis prescriptions in Germany are for the treatment of pain. Of those affected, 70 percent perceive an improvement in pain. This is shown by an interim result of the accompanying cannabis survey of the BfArM (Federal Institute for Drugs and Medical Devices), which was published in February this year. For which […]
At some point over the age of 40, fertility decreases for most women. This process is completely normal. However, this phase of upheaval and hormonal change can be marked by massive physical complaints such as mood swings, hot flashes, and sleep disturbances. In some cases, this has a considerable impact on the quality of life […]
Ehlers-Danlos Syndromes (EDS) are a group of hereditary genetic conditions that affect the connective tissue in the human body. These cellular organizational level, support our bones, skin, blood and multiple other organs. Ehlers-Danlos Syndrome: symptoms The symptoms arise when these group of cells that work together have defects, and can range from mild to life-threatening. […]
Chronic pain is a condition that is difficult to treat. The areas of the body that it affects and its origin can vary from person to person. In the recent years people have been treating themselves with opiates. These drugs are very effective, but can lead to a long-term dependence, which is partly due to […]
In 2011, in Switzerland, the revision of the Federal Law on Narcotic Drugs and Psychotropic Substances (Narcotics Law) allowed the Federal Office of Public Health (FOPH) to grant exceptional licenses for the restricted medical use of some substances which, until then, were considered forbidden. Included within these substances was, thus allowing the medical cannabis consumption in Switzerland. […]
